Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (US)

被引：0
|
作者：
Kim, Min [1 ]
McGrath, Leah J. [2 ]
Pritchard, David [2 ]
Samai, Peter [2 ]
Lin, Jay [1 ]
Stad, Robert Kees [3 ]
Spangler, Leslie [1 ]
McDermott, Michele [1 ]
Bradbury, Brian D. [4 ]
Brookhart, M. Alan [2 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
[2] NoviSci Inc, Durham, NC USA
[3] Amgen Inc, Zug, Switzerland
[4] Amgen Inc, 1 Amgen Ctr Dr, Zug, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0576
引用
收藏
页码：1169 / 1170
页数：2
相关论文
共 50 条
  • [1] COMPARATIVE EFFECTIVENESS OF OSTEOPOROSIS (OP) THERAPIES AMONG A POPULATION OF POSTMENOPAUSAL (PM) WOMEN IN THE UNITED STATES (US)
    Kim, M.
    Mcgrath, L.
    Pritchard, D.
    Samai, P.
    Lin, T.
    Stad, R.
    Spangler, L.
    Mcdermott, M.
    Bradbury, B.
    Brookhart, M.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S304 - S305
  • [2] Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
    Emily Durden
    Lionel Pinto
    Lorena Lopez-Gonzalez
    Paul Juneau
    Richard Barron
    [J]. Archives of Osteoporosis, 2017, 12
  • [3] Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
    Durden, Emily
    Pinto, Lionel
    Lopez-Gonzalez, Lorena
    Juneau, Paul
    Barron, Richard
    [J]. ARCHIVES OF OSTEOPOROSIS, 2017, 12 (01)
  • [4] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Arora, T.
    Liu, Y.
    Lin, T. -C.
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    Kim, M.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S56
  • [5] Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3979 - 3981
  • [6] Disparities in osteoporosis care among postmenopausal women in the United States
    Ruiz-Esteves, Karina N.
    Teysir, Jimmitti
    Schatoff, Daria
    Yu, Elaine W.
    Burnett-Bowie, Sherri-Ann M.
    [J]. MATURITAS, 2022, 156 : 25 - 29
  • [7] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S580 - S580
  • [8] Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Brunetti, Vanessa C.
    Lin, Tzu-Chieh
    Spangler, Leslie
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5021 - 5022
  • [9] Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert Kees
    Mcdermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (07) : 826 - 834
  • [10] Preference-Based Instrumental Variable Methods in the Comparative Effectiveness of Osteoporosis (OP) Medications in Women with Postmenopausal Osteoporosis (PMO)
    Der, Jane S.
    Critchlow, Cathy
    Xue, Fei
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 31 - 31
12345